
Encouraging news about the effectiveness of a COVID-19 vaccine candidate comes at a time when infection rates soar

Encouraging news about the effectiveness of a COVID-19 vaccine candidate comes at a time when infection rates soar

Blenders Eyewear released its first line of prescription eyewear featuring the brand’s signature bright colors and mixed metal composition. Lenses come in various colors with options for polarization, blue-light blocking technology, and a high-index option. Frame prices start at $89 for clear lenses and $109 for sunglasses.

Virtual attendance options available.

Find out what your patients are tweeting about you.

The Hong Kong-based eyewear company, Okia, released a new eyewear collection called Reshape, made entirely of 100 percent recycled material from plastic bottles.

A world-first clinical trial led by the Centre for Eye Research Australia shows vitamin B3 (nicotinamide) could play an important role in protecting against nerve cell damage that leads to blindness in glaucoma patients.

Azithromycin is a potential COVID-19 treatment, but a study warns it could increase the risk of cardiac events.

What the data shows on myopia management

New technology and management options are going to continue to hit the market. How ODs approach each one of them will determine whether ODs benefit or not.

Kala Pharmaceuticals to distribute first ocular corticosteroid for short-term treatment of dry eye

See our latest poll results

Assistant Editor Brooke Beery shares news updates for October 25, 2020.

Optometry news update

As remdesivir leads COVID-19 treatments, medications that are typically used to treat other conditions are being tested to see if any are effective against the virus.

Some 23 percent of children hospitalized with COVID-19 in Wuhan, China, had ocular manifestations


Eye care practitioners gain free access to listing of over 500 contact lenses

Kala Pharma prepares for end of year launch


Human errors including medications, administering either the wrong dose or the wrong drug, seem to increase by 18 percent

This poll is for optometrists and eyecare professionals, only. It will close on Friday, October 23, 2020.

This poll is for optometrists and eyecare professionals, only. It will close on Friday, October 23, 2020.

See our latest poll results

Ocular health became a trending topic during last night's VP debate. See what viewers had to say about Vice President Mike Pence's left eye.

This year’s call to action is “Hope In Sight”

There is treatment hope for neurotrophic keratitis, a rare disease affecting the cornea.

Study provides encouraging results in the treatment of symptomatic Alzheimer’s patients.

Panellists dive into the newest developments in the contact lens space
